Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group StudyMark C Genovese, Katerina Jarosova, Dorota Cieślak, et al.
The New England Journal of Medicine|May 17, 2023
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid ArthritisJay Tuttle, Edit Drescher, Jesus Abraham Simón-Campos, et al.
The Journal of Rheumatology|December 1, 2007
Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) TrialPhilip J Mease, Dennis A Revicki, Jacek Szechinski, et al.
BMC Rheumatology|March 27, 2023
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE studyAaron Broadwell, Joy Schechtman, Douglas Conaway, et al.
RMD Open|October 1, 2019
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension studyXenofon Baraliakos, Juergen Braun, Atul Deodhar, et al.
The Lancet. Rheumatology|January 26, 2024
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot studyMark C Genovese, Norman B Gaylis, David Sikes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2024
Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 StudyAlan Kivitz, Liliana Sedova, Melvin Churchill, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2008
Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosisE Michael Lewiecki, Tony M Keaveny, David L Kopperdahl, et al.
Arthritis and Rheumatism|November 13, 2003
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trialJohn C Davis, Désirée Van Der Heijde, Jurgen Braun, et al.
Annals of the Rheumatic Diseases|June 23, 2017
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritisJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Pageof 10